Effect of St. John's Wort Oil on Skin Moisture in Intensive Care Patients

August 7, 2024 updated by: Ayşenur ÖZENÇ KOLUTEK, Eskisehir Osmangazi University
The study was conducted to evaluate the effect of St. John's wort oil application on skin moisture in intensive care patients. The study is a prospective pre-test-post-test controlled experimental research.It has been observed that St. John's wort oil has an effect on the skin moisture of intensive care patients.

Study Overview

Status

Completed

Conditions

Detailed Description

Effect of St. John's Wort oil on skin moisture in intensive care patients.

The study was conducted to evaluate the effect of St. John's wort oil application on skin moisture in intensive care patients. The study is a prospective pre-test-post-test controlled experimental research.

Research data was collected at Eskisehir City Hospital, between September 1, 2023 and March 1, 2024. Descriptive Characteristics Form, Braden Risk Assessment Scale, Moisture Meter Device and St. John's wort oil were used to collect data. In the sample size power analysis of the study, the total number of samples was found to be 138 with test power ( 1-β) 0.80, α(alpha)=0.05, effect level 0.10. The research was conducted on a total of 140 patients, 70 in the experimental group and 70 in the control group. St. John's wort oil was applied to the experimental group and routine nursing care was applied to the control group for 21 days. Independent Sample t test, ANOVA (Repeated Measures test), Mann- Whitney U test, Wilcoxon test and Pearson-χ 2 cross tables were used to evaluate the data.

Study Type

Interventional

Enrollment (Actual)

140

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Eskişehir, Turkey
        • Ayşenur ÖZENÇ KOLUTEK

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Admission to intensive care due to internal diseases diagnosis
  • The patient is immobile
  • The area to be applied is determined as the Coccyx and the tissue in this area must be intact.
  • No allergy to St. John's Wort oil
  • No circulatory disorders in the applied area

Exclusion Criteria:

  • Having a complicated diagnosis such as cancer
  • Having any disease that has spread to the entire skin
  • Having an allergy to topical medications or plant extracts
  • The patient has different variations such as surgical operation and intensive care change (post-operative follow-up patient)
  • The patient has a diagnosis of a skin disease such as dermatitis
  • A wound in the coccyx area

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group

70 experimental group patients participated in the study; St. John's wort oil was applied to the coccyx area(width 10cm, length 10cm) of the patient included in the study at the same times every day for 21 days, starting from Day 0.

The first day of hospitalization is considered day 0 and skin moisture is measured. The skin is cleaned and dried. 4 or 5 drops of St. John's wort oil were dropped onto the area and applied with a cotton pad.The next day, skin moisture is measured then the skin is cleaned and dried and St. John's wort oil is applied again. This Process continues for 21 days and is recorded.

To examine the effect of regularly applied St. John's Wort oil on skin moisture.
Other: Control Group

70 control group patients participated in the study; The skin protective barrier cream used in routine care of the coccyx region (width 10 cm, length 10 cm) of the patient included in the study was applied at the same hours every day for 21 days, starting from day 0.

The first day of hospitalization is considered day 0 and skin moisture is measured. The skin is cleaned and dried.Barrier cream is applied to the patient's coccyx area.The next day, at the same time, skin moisture is measured, then the skin is cleaned and dried, and barrier cream is applied again.Transactions are made and recorded every day for 21 days.

To examine the effect of regularly applied barrier cream on skin moisture.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experimental Group Results
Time Frame: Measurements were made every day from day 0 to day 20. Measurements were made every day from day 0 to day 20.
Moisture measurement of the coccyx area was performed with a skin moisture meter.
Measurements were made every day from day 0 to day 20. Measurements were made every day from day 0 to day 20.
Control Group Results
Time Frame: Measurements were made every day from day 0 to day 20. Measurements were made every day from day 0 to day 20.
Moisture measurement of the coccyx area was performed with a skin moisture meter.
Measurements were made every day from day 0 to day 20. Measurements were made every day from day 0 to day 20.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ayşenur ÖZENÇ KOLUTEK, researcher, student of the institution

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2023

Primary Completion (Actual)

March 1, 2024

Study Completion (Actual)

March 1, 2024

Study Registration Dates

First Submitted

August 3, 2024

First Submitted That Met QC Criteria

August 7, 2024

First Posted (Actual)

August 9, 2024

Study Record Updates

Last Update Posted (Actual)

August 9, 2024

Last Update Submitted That Met QC Criteria

August 7, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • EskisehirOU-SBF-AOK-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skin Moisture

Clinical Trials on St. John's wort oil

Subscribe